Technologies related to In vivo data available (animal)

Title
Encapsulated Streptococcus Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development
Ref: E-009-2018-0 | Updated: Feb 26, 2019
Potential Treatment for sickle-cell disease and thalassemia
Ref: E-200-2018-0 | Updated: Jan 17, 2019
Universal Influenza Virus Probes for Enrichment of Influenza Viral Sequences
Ref: E-032-2018-0 | Updated: Nov 8, 2018
Licensing Availability: Methods of Diagnosing and Treating CHAPLE, A Newly Identified Orphan Disease
Ref: E-251-2016-0 | Updated: Sep 7, 2018
Real-time PCR Detection of Streptococcus pneumoniae with High Sensitivity and Specificity
Ref: E-288-2013-0 | Updated: Aug 1, 2018
New Anti-Influenza Virus Neuraminidase 9 (N9) Monoclonal Antibody – for Prevention or Treatment of H7N9 Influenza (Flu) A with Less Likelihood of Drug Resistance
Ref: E-200-2016-0 | Updated: Jun 20, 2018
Novel Peptide of Streptococcus pneumoniae Surface Adhesion A (PsaA) Protein Associated with Adherence and Uses Thereof – for Vaccine Candidate, Therapeutic and Diagnostic Development
Ref: E-338-2013-0 | Updated: Jun 13, 2018
Novel Fourth Human Ebolavirus species, Bundibugyo ebolavirus – Compositions and Methods for Vaccine, Therapeutics and Highly Sensitive Diagnostic Assay Development
Ref: E-159-2013-0 | Updated: Jun 7, 2018
Potential New Drugs for Treating or Preventing Pruritus
Ref: E-485-2013-1 | Updated: Jun 7, 2018
Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
Ref: E-293-2014/1 | Updated: Feb 14, 2018
Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
Ref: E-293-2014-1 | Updated: Feb 14, 2018
Regenerative Therapy for Cartilage Damage
Ref: E-152-2017-0 | Updated: Jan 25, 2018
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016-0 | Updated: Jun 22, 2018
Development of a Transferrable Norwalk Virus Epitope and Detector Monoclonal Antibody
Ref: E-101-2013/0 | Updated: Sep 5, 2017
Whole Animal Feeding Flat (WAFFL): A High-throughput Platform for the Automated Handling of Flies
Ref: E-034-2015/0 | Updated: Nov 7, 2017
Transgenic Mice Expressing CNO-sensitive Gq- or Gs-coupled Designer Receptors Selectively in Pancreatic Beta Cells
Ref: E-197-2016-0 | Updated: Apr 17, 2017
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011-0 | Updated: May 16, 2018
Polyvalent Influenza Virus-Like Particles (VLPs) and Use as Vaccines
Ref: E-195-2014/0 | Updated: Dec 1, 2016
Methods of Making and Using Dopamine D3 Receptor Selective Antagonists/Partial Agonists
Ref: E-053-2016/0 | Updated: Mar 8, 2017
Use of Roseomonas Species to Treat Eczematous (Atopic Dermatitis) Skin Disease
Ref: E-099-2016-0 | Updated: Oct 27, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015/0 | Updated: Jun 27, 2016
Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
Ref: E-208-2015-0 | Updated: Jan 4, 2016
Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
Ref: E-292-2015-0 | Updated: May 24, 2016
Enhancing Adoptive T Cell Therapy Using c-Myb
Ref: E-232-2015-0 | Updated: Nov 4, 2015
Optimized Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia
Ref: E-039-2015/0 | Updated: Apr 26, 2017
Detection and Discrimination of Classical and Atypical L-Type BSE Strains by RT-QuIC
Ref: E-048-2015-0 | Updated: May 7, 2018
Prevention or Treatment of Viral Infections by Inhibition of the Histone Methyltransferases EZH1/2
Ref: E-141-2015/0 | Updated: Aug 10, 2015
mNFHcre Transgenic Mice
Ref: E-293-2009-0 | Updated: Aug 10, 2015
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015-0 | Updated: May 1, 2019
Novel Treatment for Anemia and Polycythemia: AVPR1B Molecules Modulating Erythropoiesis
Ref: E-619-2013-0 | Updated: Aug 6, 2015
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015-0 | Updated: May 1, 2019
WNT1-Induced Secreted Protein-1 Knockout Mouse Model
Ref: E-234-2015-0 | Updated: Aug 6, 2015
Bispecific Chimeric Antigen Receptors to CD22 and CD19 for Treating Hematological Cancers
Ref: E-106-2015-0 | Updated: Aug 22, 2018
Magnetic Resonance Magnification Imaging
Ref: E-252-2014-0 | Updated: Jan 12, 2017
Boron Amino Acid Mimetics for PET Imaging of Cancer
Ref: E-135-2015/0 | Updated: Jun 29, 2015
A Novel Therapeutic Vector for Hemoglobin Disorders
Ref: E-165-2014-0 | Updated: Sep 21, 2015
Novel Dopamine D2 Receptor Antagonists and Methods of Their Use
Ref: E-030-2013/0 | Updated: Sep 5, 2017
Live Attenuated Japanese Encephalitis Virus Vaccine
Ref: E-231-2014/0 | Updated: Jul 1, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014/0 | Updated: Jul 1, 2015
LRRK2 Inhibitors: Novel Treatment for Intestinal Bowel Disorders
Ref: E-070-2014/0 | Updated: Mar 22, 2016
Octopod (8-Pointed Star) Iron Oxide Nanoparticles Enhance MRI T2 Contrast
Ref: E-314-2013-0 | Updated: Jun 5, 2018
T-cell Chimeric Receptors of TSLPR for Diagnosis and Immunotherapy of Cancer
Ref: E-008-2014-0 | Updated: Nov 20, 2014
High-Titer, Fast-Growth Chimeric Dengue/West Nile Viruses for Vaccine and Diagnostics Development
Ref: E-168-2014/0 | Updated: Nov 14, 2014
The Use of Chimeric Antigen Receptor to Control HIV Infection
Ref: E-212-2014/0 | Updated: Sep 9, 2015
A Current Amplifier for Local Coil Pre-amplification of NMR/MRI Signals
Ref: E-122-2014-0 | Updated: May 18, 2018
A Novel X-ray Grating to Enhance Phase Contrast Imaging
Ref: E-114-2013-0 | Updated: May 18, 2018
A Novel Demodulation System in X-ray Imaging
Ref: E-113-2013-0 | Updated: May 18, 2018
Inhibition of HIV Infection through Chemoprophylaxis Using Emtricitabine and Tenofovir
Ref: E-195-2013-0 | Updated: Sep 25, 2014
Novel Epstein-Barr Virus Vaccines
Ref: E-531-2013/0 | Updated: Dec 17, 2015
Implantable Medical Devices with Electric Current Retrieval Assist
Ref: E-088-2014/0 | Updated: Aug 6, 2014
AAV-Vectors for Treatment of Glycogen Storage Disorders
Ref: E-552-2013-0 | Updated: Aug 6, 2014
Small Molecule Imaging of Fungi by Positron Emission Tomography Scanning
Ref: E-449-2013-0 | Updated: Feb 13, 2017
Polypeptides and Methods for Enhancing and Balancing Monovalent or Multivalent Flavivirus Vaccines
Ref: E-275-2013-0 | Updated: Aug 23, 2018
Treatment of Chronic Kidney Disease with Synthetic Amphipathic Peptides
Ref: E-743-2013/0 | Updated: Jun 2, 2014
Improved Acoustic Plethysmograph System for Noninvasive Measurement of Pulmonary Function
Ref: E-290-2013/0 | Updated: Jun 9, 2014
Multi-specific Chimeric Antigen Receptors Against HIV
Ref: E-170-2013/0 | Updated: Oct 23, 2017
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: E-736-2013-0 | Updated: Apr 14, 2014
Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
Ref: E-751-2013/0 | Updated: Nov 18, 2015
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013-0 | Updated: May 14, 2018
Dengue Vaccines: Tools for Redirecting the Immune Response for Safe, Efficacious Dengue Vaccination
Ref: E-289-2013-0 | Updated: Mar 18, 2014
Rabies Vaccine for the Oral Immunization of Domesticated Animals, Wildlife and Feral Animals
Ref: E-470-2013/0 | Updated: May 24, 2016
Computer Controlled Aerosol Generator with Multi-Walled Carbon Nanotube Inhalation Testing Capabilities
Ref: E-156-2013/0 | Updated: Mar 17, 2014
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012/0 | Updated: Apr 15, 2014
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013/0 | Updated: Feb 19, 2014
CD40 Ligand: Adjuvant for Enhanced Immune Response to Respiratory Syncytial Virus
Ref: E-233-2013/0 | Updated: Feb 6, 2014
Recombinant Nucleic-Acid Based Flavivirus Nucleic Acids for Development of Vaccines and/or Sero-diagnostics
Ref: E-341-2013/0 | Updated: Jan 28, 2014
Stable, Early-stage Biomarker for Diagnosis of Bacillus anthracis Infection and Anthrax Vaccine Development
Ref: E-474-2013/0 | Updated: Mar 3, 2017
Virus Replicon Particles as Rift Valley Fever Vaccines
Ref: E-272-2013/0 | Updated: Aug 8, 2016
Multi-Antigenic Peptide(s) Vaccine and Immunogen for Conferring Streptococcus pneumoniae Immunity
Ref: E-248-2013/1 | Updated: Jan 27, 2014
Select M. tuberculosis Peptides as Mucosal Vaccines Against Pulmonary Tuberculosis
Ref: E-192-2013/0 | Updated: Jan 27, 2014
Exposure and Activity Detection Assays for Anthrax Lethal Factor and Lethal Toxin
Ref: E-196-2013/0 | Updated: Mar 3, 2017
Sensitive Method for Detection and Quantification of Anthrax, Bordetella pertussis, Clostridium difficile, Clostridium botulinum and Other Pathogen-Derived Toxins in Human and Animal Plasma
Ref: E-167-2013/0 | Updated: Mar 3, 2017
Respiratory Syncytial Virus Immunogens for Vaccine and Therapeutics Development
Ref: E-197-2013/0 | Updated: Jan 16, 2014
Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine
Ref: E-081-2013-0 | Updated: Jun 22, 2018
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013-0 | Updated: Jun 7, 2018
Bispecific Antibodies to Target Latent HIV-1 Infection
Ref: E-071-2012/0 | Updated: Jan 6, 2014
Human Rotavirus Strains and Vaccines for Neonatal Childhood Protection
Ref: E-150-2013-0 | Updated: Feb 13, 2014
Novel Rift Valley Fever Virus Vaccines
Ref: E-254-2013/2 | Updated: Dec 23, 2013
AAV-Aquaporin-1 Gene Therapy for Sjogren's Syndrome
Ref: E-139-2011-1 | Updated: May 1, 2019
AAV-Aquaporin-1 Gene Therapy for Sjogren's Syndrome
Ref: E-139-2011/1 | Updated: Dec 14, 2016
Use of Antisense Oligodeoxynucleotides for Inhibiting JC Virus
Ref: E-547-2013/0 | Updated: Feb 11, 2016
Mouse Model for Methylmalonic Acidemia, an Inherited Metabolic Disorder
Ref: E-285-2011/1 | Updated: Dec 3, 2013
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013-0 | Updated: Jun 14, 2018
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012/0 | Updated: Aug 11, 2015
Antagonists of Hyaluronan Signaling for Treatment of Airway Diseases
Ref: E-080-2012/0 | Updated: Oct 3, 2017
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011/0 | Updated: Jun 18, 2014
Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease
Ref: E-101-2010/0 | Updated: Sep 21, 2015
Therapeutic Peptide Treatment for Dyslipidemic and Vascular Disorders
Ref: E-138-2008-0 | Updated: Aug 8, 2016
Non-Invasive In Vivo MR Method to Image Salient Features of Nerves
Ref: E-079-2003-1 | Updated: Sep 15, 2015
Live Attenuated Vaccine to Prevent Disease Caused by West Nile Virus
Ref: E-357-2001-1 | Updated: Sep 10, 2015
The Use of alpha-4 beta-7 integrin Inhibitors to Inhibit HIV Transmission and Infection
Ref: E-055-2007/0 | Updated: Feb 28, 2014
ApoA-1 Mimetic Peptides Promoting Lipid Efflux from Cells for Treatment of Vascular Disorders
Ref: E-114-2004-0 | Updated: Nov 29, 2016
Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson's and Alzheimer's Disease
Ref: E-130-2004-0 | Updated: May 4, 2018
Oral Treatment of Hemophilia
Ref: E-281-2001/0 | Updated: Dec 4, 2013
Subscribe to Technologies related to In vivo data available (animal)